JPS5842638A - Polypropylene composition having improved radiation resistance - Google Patents

Polypropylene composition having improved radiation resistance

Info

Publication number
JPS5842638A
JPS5842638A JP13980581A JP13980581A JPS5842638A JP S5842638 A JPS5842638 A JP S5842638A JP 13980581 A JP13980581 A JP 13980581A JP 13980581 A JP13980581 A JP 13980581A JP S5842638 A JPS5842638 A JP S5842638A
Authority
JP
Japan
Prior art keywords
polypropylene
weight
hydroxy
hindered amine
irradiation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP13980581A
Other languages
Japanese (ja)
Other versions
JPS6235413B2 (en
Inventor
Toru Matsumura
徹 松村
Kazuharu Hirano
平野 和治
Kan Nakajima
中島 完
Teiichi Yoshitake
吉武 悌一
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Terumo Corp
Tonen General Sekiyu KK
Original Assignee
Terumo Corp
Toa Nenryo Kogyyo KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Terumo Corp, Toa Nenryo Kogyyo KK filed Critical Terumo Corp
Priority to JP13980581A priority Critical patent/JPS5842638A/en
Priority to FR8215128A priority patent/FR2512453B1/en
Priority to BE0/208963A priority patent/BE894327A/en
Priority to AU88083/82A priority patent/AU548837B2/en
Publication of JPS5842638A publication Critical patent/JPS5842638A/en
Priority to AU43716/85A priority patent/AU567617B2/en
Priority to AU43717/85A priority patent/AU567618B2/en
Publication of JPS6235413B2 publication Critical patent/JPS6235413B2/ja
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08KUse of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00Use of organic ingredients
    • C08K5/16Nitrogen-containing compounds
    • C08K5/34Heterocyclic compounds having nitrogen in the ring
    • C08K5/3467Heterocyclic compounds having nitrogen in the ring having more than two nitrogen atoms in the ring
    • C08K5/3477Six-membered rings
    • C08K5/3492Triazines
    • C08K5/34924Triazines containing cyanurate groups; Tautomers thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/02Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using physical phenomena
    • A61L2/08Radiation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/143Stabilizers
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08KUse of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00Use of organic ingredients
    • C08K5/16Nitrogen-containing compounds
    • C08K5/34Heterocyclic compounds having nitrogen in the ring
    • C08K5/3412Heterocyclic compounds having nitrogen in the ring having one nitrogen atom in the ring
    • C08K5/3432Six-membered rings
    • C08K5/3435Piperidines
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08KUse of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00Use of organic ingredients
    • C08K5/49Phosphorus-containing compounds
    • C08K5/51Phosphorus bound to oxygen
    • C08K5/52Phosphorus bound to oxygen only
    • C08K5/524Esters of phosphorous acids, e.g. of H3PO3
    • C08K5/526Esters of phosphorous acids, e.g. of H3PO3 with hydroxyaryl compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Surgery (AREA)
  • Vascular Medicine (AREA)
  • Compositions Of Macromolecular Compounds (AREA)

Abstract

PURPOSE:To provide the titled propylene compsn. which little suffers lowering in physical properties and discoloration due to irradiation, by blending a specified hindered amine compd. and a phenolic antioxidant. CONSTITUTION:0.05-0.3pt.wt. heterocyclic hindered amine compd. such as di- (2,2,6,6-tetramethyl-4-piperidyl) sebacate and 0.01-0.04pt.wt. phenolic antioxidant [1,3,5-tris(3-hydroxy-2,6-dimethyl-4-alkylbenzyl)isocyanurate wherein alkyl is a 2-12C branched alkyl such as tert-butyl]are blended with 100pts.wt. polypropylene such as a crystalline propylene (co)polymer. Since moldings prepd. from the resulting compsn. can be sterilized safely and effectively by ultraviolet light irradiation, the moldings are suitable for use as food packaging materials, medical instrument, etc.

Description

【発明の詳細な説明】 本発明は耐放射線性O改良されたポリプロピレン組成物
に関するもOである。
DETAILED DESCRIPTION OF THE INVENTION This invention relates to polypropylene compositions with improved radiation resistance.

従来、ポリプロピレンには耐熱性及び加工安定性等0物
性を維持向上させるために用途に応じて種々の安定剤及
び添加剤が添加されている。
Conventionally, various stabilizers and additives have been added to polypropylene in order to maintain and improve its physical properties such as heat resistance and processing stability, depending on the purpose.

また、注射器、ビンセット、クランプあるいは食品包装
用バッグ、容器類、フィルム等の医療器具や食品楓装材
O殺菌は、従来一般的には煮沸あるいはガス殺菌が行わ
れている。特にディスポ−ずプル医療器具O殺dllF
i、エチレンオキサイドの処理が行われているが、最近
まで一般に安全であると−みなされてい友エチレンオキ
サイドは、これが変異#S発素及び発ガン物質としてO
疑いもあるために1残留エチレンオキサイド及び副生成
物O許容量も下けられておシ、残留ガスO置換、除去及
びそれに引続く殺菌確認OためO無菌試験を必要とし、
放射線殺菌処理に対して相対的に処理コストが高くなる
。従って、ディスポ−ずプル医療器具OR菌はエチレン
オキすイド処理から放射線(r線)照射殺菌方法が効果
的と考えられ採用される方向にある。
In addition, medical instruments such as syringes, bottle sets, clamps, food packaging bags, containers, films, and food wrapping materials have conventionally been sterilized by boiling or gas sterilization. Especially disposable pull medical equipment OdllF
i. Ethylene oxide has been treated with ethylene oxide, which until recently was generally considered safe.
Due to the suspicion, the allowable amount of residual ethylene oxide and by-products has been lowered, and a sterility test is required to replace and remove the residual gas and confirm subsequent sterilization.
The processing cost is relatively high compared to radiation sterilization processing. Therefore, sterilization methods ranging from ethylene oxide treatment to radiation (r-ray) irradiation are considered to be effective and are being used to treat OR bacteria in disposable medical instruments.

しかしながら、ポリプロピレン組成物を用いえ医療器真
中食品包装材Fi1通常殺菌線量0目安とされる15メ
ガラドS度O放射線照射によって著しく分解、劣化が惹
起され機械的強直1低下させたシ、低“分子量O溶出性
成分を増したり、ま九、一般に酸化防止その他の目的で
加えられている各種安定剤、改質剤%0添加剤類の変質
によ)著しく着色する尋O間mがある。従って、ポリプ
ロピレンO医療器具、主として注射器の放射線処理に関
しては次のような提案がなされている。ガえば、イノシ
アヌレート基を含有するフェノール性抗酸化剤とチオ共
動薬とtプロピレンポリマーに混入すること(特開昭5
5−1i57135号公報)、C−オレフィンO結晶性
重合体にヒンダードアミン窒素原子させ友製品(特開昭
55−1919?号公報)等が知られている。
However, when polypropylene compositions are used, they are significantly decomposed and deteriorated by irradiation with 15 megarads, which is considered to be the standard for 0 sterilization doses, and mechanical toughness is reduced. There is a possibility of significant coloring (due to an increase in O-eluting components, or due to deterioration of various stabilizers, modifiers, and additives that are generally added for antioxidant and other purposes). Regarding the radiation treatment of polypropylene O medical devices, mainly syringes, the following proposals have been made: For example, mixing phenolic antioxidants and thiosynervates containing inocyanurate groups into t-propylene polymers ( Japanese Patent Publication No. 5
5-1i No. 57135), and a product in which a C-olefin O crystalline polymer has a hindered amine nitrogen atom (Japanese Patent Application Laid-open No. 55-1919?) are known.

しかしながら、これらの先行技術について前者は物性、
着色、衛生毒性Oバランスを保った改良【図る友めには
必ずし吃十分ではなく、後者については着色についての
改良はなされているもOO加工工程、物性、耐熱寿命が
必ずしも十分ではなく、現在迄Oとこる必ずしも満足で
きる品質、性能OもO−a得られていない。
However, regarding these prior art, the former is based on physical properties,
Improvements that maintain a balance between coloring, hygiene, toxicity, and O are not necessarily sufficient for those who aim to do so.As for the latter, although improvements have been made regarding coloring, the O processing process, physical properties, and heat resistance life are not necessarily sufficient; Until now, satisfactory quality and performance have not been obtained.

本発明者らは放射−照射による変色と物性低下O少ない
ポリプロピレンについて検討を行り九結果、本発明を完
成したのである。
The present inventors conducted research on polypropylene with less discoloration and less loss of physical properties due to radiation and irradiation, and as a result, completed the present invention.

すなわち、本発明はポリプロピレン10.0重量部にヘ
テロサイクリックヒンダードアミン系 ゛化合物110
5〜αS重量部及びt45−)リス(S−ヒドロキシ−
2,4−ジメチル−4−アルキル−ベンジル)インシア
ヌレート(但し、アルキルFiO,% C1,0分岐ア
ルキル基である)[101〜a04重量部とt配合した
ことt特徴とする耐放射線性O改良され九ポリプロピレ
ン組成物である。
That is, in the present invention, a heterocyclic hindered amine compound 110 is added to 10.0 parts by weight of polypropylene.
5~αS parts by weight and t45-)lith(S-hydroxy-
2,4-dimethyl-4-alkyl-benzyl)in cyanurate (alkyl FiO,% C1,0 branched alkyl group) [101 to a04 parts by weight and t are blended t Characterized by radiation resistance O Improved nine polypropylene compositions.

本発明で用いるポリプロピレンは、通常成形品材料とし
て広く使用されている結晶性ポリプロピレンまえはプロ
ピレンを主体としえ結晶性O共重合体である。−見は、
プ1ピレンを主体とした結晶性O共重合体としては、エ
チレンープaピレンランダム共重合体、エチレン−プロ
ピレンプロッタ共重合体、プロピレン−1−ブテン共重
合体等があけられる。
The polypropylene used in the present invention is a crystalline polypropylene widely used as a material for molded articles, and a crystalline O copolymer mainly composed of propylene. -See,
Examples of the crystalline O copolymer mainly composed of prop-1-pyrene include ethylene-propylene random copolymer, ethylene-propylene plotter copolymer, propylene-1-butene copolymer, and the like.

本発明で添加されるヘテロナイフリックヒンダードアミ
ン系化合物(以下ヒンダードアイン系化合物という>F
i、ヒンダードアミン窒素原子及び任意に他の異原子好
ましくtit窒素1fcは酸素を含む6員複素環からな
るものである。ガえげ、ジー(2,2,6,6−テトラ
メチル−4−ビヘリシル)セバケート、4−ベンゾイル
オキシ−z2.t6テトラメチルビベリジン、コノ・り
酸とN−(2−とドロキシエチル) −2,2,46テ
トラメチルー4−ヒドロキシピペリジンとoait合物
、t2.&4−テトラ(2,2,&6テトラメテルー4
−ピペリジル)−ブタンテトラカルボキシレート、t4
−ジー(2,2,44−テトラメチル−4−ピペリジル
)−2,3−ブタンジオン。
Heteronitric hindered amine compound (hereinafter referred to as hindered amine compound) added in the present invention
i, a hindered amine nitrogen atom and optionally other heteroatoms. Preferably tit nitrogen 1fc consists of a 6-membered heterocycle containing oxygen. Gaege, di(2,2,6,6-tetramethyl-4-bihelicyl) sebacate, 4-benzoyloxy-z2. t6 tetramethyl biveridine, cono-phosphoric acid and N-(2- and droxyethyl)-2,2,46 tetramethyl-4-hydroxypiperidine and oait compound, t2. &4-tetra(2,2,&6tetrameter-4
-piperidyl)-butanetetracarboxylate, t4
-di(2,2,44-tetramethyl-4-piperidyl)-2,3-butanedione.

トリス−(2,2,44−テトラメチル−4−ピペリジ
ル)トリメリゾート、L2.2.瓜6−ペ/タメチルー
4−ピペリジルステアレー)、L2,2゜46−ベンタ
メチルー4−ピペリジルn−オクトエート、ビス−(L
2.2.46−ベンタメチルー4−ピペリジル)セバケ
ート、トリス−(2゜2.46−テトラメチル−4−ピ
ペリジル)−二トリルアセテート、4−ヒドロキシ−2
,2,44−テトラメチルピリジン、4−ヒドロキシ−
tLz&6−ペンタメチルピペリジン郷があげられる。
Tris-(2,2,44-tetramethyl-4-piperidyl) trimeresolt, L2.2. Melon 6-pe/tamethyl-4-piperidyl stearate), L2,2゜46-bentamethyl-4-piperidyl n-octoate, bis-(L
2.2.46-bentamethyl-4-piperidyl) sebacate, tris-(2°2.46-tetramethyl-4-piperidyl)-nitrile acetate, 4-hydroxy-2
, 2,44-tetramethylpyridine, 4-hydroxy-
Examples include tLz&6-pentamethylpiperidine.

そしてこれらのうちでは、ジー(2,2,46−テトラ
メチル−4−ピペリジル)セバケイトまたはコハク酸と
菖−(2−ヒト−キシエチル) −2,2,&6−チト
ラメチルー4−ヒドロキシピペリジンO縮合物が特に好
ましい。
And among these, di(2,2,46-tetramethyl-4-piperidyl)sebacate or succinic acid and irises-(2-human-xyethyl)-2,2,&6-titramethyl-4-hydroxypiperidine O condensate is particularly preferred.

本発明て添加されるL&5−)リス(S−ヒドロキシ−
2,6−シメチルー4−アルキル−ベンジル)インシア
ヌレートは、アルキルがO8−(!1.0分岐アルキル
基であるヒンダードフェノール系O酸化防止削である。
L&5-)lith(S-hydroxy-) added in the present invention
2,6-dimethyl-4-alkyl-benzyl)in cyanurate is a hindered phenolic O-oxidation inhibitor in which the alkyl is an O8-(!1.0 branched alkyl group).

例えば% t&5−トリス(5−ヒドロキシ−L6−ジ
メテルー4−イングロビルーペンジル)インシアヌレー
ト。
For example, % t&5-tris(5-hydroxy-L6-dimethelu-4-ingrobyrupendyl)in cyanurate.

1.45−トリス(S−ヒドロキシ−2,6−シメチル
ー4−第三プチル−ベンジA−)インシアヌレート、L
!L5−)リス(5−ヒドロキシ−λ6−シメチルー4
−IKニブチル−ベンジル)インシアヌレート、L&5
−)リス(5−ヒドロキシ−2,4−ジメチル−4−イ
ンブチルーベンジル)インシアヌレート郷があけられる
が、これらのうちでは111−トリス(5−ヒドロキシ
−L6−シメチルー4−第三プチル−ベンジル)インシ
アヌレートが%に好オしい。
1.45-Tris(S-hydroxy-2,6-dimethyl-4-tert-butyl-bendiA-)in cyanurate, L
! L5-) lis(5-hydroxy-λ6-cymethyl-4
-IK Nibutyl-benzyl) incyanurate, L&5
-) Lis(5-hydroxy-2,4-dimethyl-4-butylbenzyl)incyanurate, among which 111-tris(5-hydroxy-L6-dimethyl-4-tert-butyl -benzyl)in cyanurate is preferred.

上記安定剤OポリプロピレンへO添加量はポリフロピレ
ン100重量部に対しヒンダード系アミン化合物O場合
Fiaos〜aA重量部好ましくは11〜(12重量部
である。tた% 1.45−トリス(5−ヒドロキシ−
λ6−シメチルー4−フルキルーベンジル)インシアヌ
レート(以下フェノール系酸化防止剤という)は[10
1〜(L04重量部好ましくi;ino 2〜[Lo 
5重量部である。
The amount of O added to the stabilizer O polypropylene is preferably 11 to 12 parts by weight in the case of hindered amine compound O per 100 parts by weight of polypropylene. −
λ6-dimethyl-4-furkylbenzyl)in cyanurate (hereinafter referred to as phenolic antioxidant) is [10
1~(L04 parts by weight preferably i; ino 2~[Lo
5 parts by weight.

また、これらヒンダードアミン系化合物及びフェノール
系酸化防止剤等の安定剤OポリプロピレンへO添加方法
は、一般に用いられる株加方法によって行われる。ガえ
ば、ポリプロピレンに安定剤を配合し、予備混合tした
後押出機で混線する方法か適当である。
Further, the method of adding stabilizers such as these hindered amine compounds and phenolic antioxidants to polypropylene is carried out by a generally used stock addition method. For example, a suitable method is to mix a stabilizer with polypropylene, premix it, and then mix it in an extruder.

なお、本発明Oポリプロピレフ組成物゛には前記O安定
剤の外に中和剤、滑剤、離型剤、造核剤を添加すること
ができる。
In addition to the above-mentioned O stabilizer, a neutralizing agent, a lubricant, a mold release agent, and a nucleating agent can be added to the O-polypropyref composition of the present invention.

以上1本発明Oポリプロピレン組成物は、放射線O照射
による変色も極〈僅かで物性O低下も少くまた安全衛生
を損わないため、医療器具、食品但装材、容器類等O用
途として好適である。
The polypropylene composition of the present invention is suitable for applications such as medical instruments, food packaging materials, containers, etc., because the polypropylene composition of the present invention undergoes very little discoloration due to irradiation with radiation, causes little deterioration in physical properties, and does not impair safety and hygiene. be.

以下、実施例によシ放射線によるポリプロピレン組成物
O変色及び物性O変化について示す。
Hereinafter, the discoloration and physical property changes of polypropylene compositions due to radiation will be shown in Examples.

なお Sは重量部である。Note that S is parts by weight.

実施例1 エチレン含有量2−0重量−、メルト70−レート(ム
8TM  D−1238%  250 ℃ 、   2
140  f 以下輩νRと略す)&If710分のエ
チレン−プロピレンランダム共重合体100重量部に表
−1に示す割合O安定剤、中和剤(ステアリン酸カルシ
ウム)(Lt重量部及び造核剤(LA2.4−ジペジリ
デンンルビトール)a2重量部とを配合し、ヘンシェル
(キサ−で予I11混合を行い。
Example 1 Ethylene content 2-0% by weight, melt rate 70% (Mu8TM D-1238% 250°C, 2
To 100 parts by weight of an ethylene-propylene random copolymer of 140 f (hereinafter abbreviated as νR) & If710, O stabilizer, neutralizing agent (calcium stearate) (part by weight of Lt) and nucleating agent (LA2. 4-dipezylidene rubitol) a and 2 parts by weight, and pre-mixing was carried out using Henschel (Kisa).

次いでこO温合物を210’OO押出機で溶融混練して
ベレット化した。これらのベレットを用いて射出成形機
により40■X40mX1mO試験片1成形した。この
試験片にコバルト−400線源を使用して五5メガラド
t)rlNt10時間照射した。rljiA照射前後O
色相は、J工8 Z−81220照明および受光O幾何
学的条件10方法に従ってスガ試験器■製カラーメータ
ームUD−0111−2(45−0)デジタル#1色色
差計で測定した。測定値(b値)0色相は、−50未満
を無着色(O)、−翫O〜−48未満を極〈僅かに黄色
(0)、−毛8〜−40未満を微黄色(Δ)及び−LO
以上を黄色(X)とした。
Next, this O-temperature mixture was melt-kneaded using a 210'OO extruder to form pellets. Using these pellets, one 40 mm x 40 m x 1 mO test piece was molded using an injection molding machine. The specimen was irradiated with a cobalt-400 source for 10 hours at 55 megarads. rljiA before and after irradiation O
Hue was measured using a Colormeter UD-0111-2 (45-0) Digital #1 Color Difference Meter manufactured by Suga Test Instruments, in accordance with J Engineering 8 Z-81220 Illumination and Light Reception O Geometric Conditions 10 Method. Measured value (b value) 0 hue is: less than -50 is uncolored (O), -0 to less than -48 is very slightly yellow (0), and from -8 to less than -40 is slightly yellow (Δ) and -LO
The above was designated as yellow (X).

なお、r線照射稜O色相は測定値が−4,8未満O極僅
かに黄色Oも0迄を許容基準とした。また、物性の変化
は、γ線照射9 □ MiPHの酸化及び135℃オー
プンでO耐熱寿命の1価を行いその結果を表−1に示し
た。
The acceptable standard for the hue of the r-ray irradiated edge was that the measured value was less than -4.8, very slightly yellow, and even 0. In addition, changes in physical properties were determined by oxidation of γ-ray irradiation 9 □ MiPH and monovalence of O heat resistance life at 135° C. open, and the results are shown in Table 1.

なお、比較Oために本発明O安定剤0組合せ使用いない
−t)または、添加量を越えるもOについても同様に試
験片を成形し、r線照射後の色相及び物性O変化を測定
評価して、その結果上表−1に併記した。
For comparison, test pieces were formed in the same manner for O (not using 0 combinations of the O stabilizer of the present invention) or for O exceeding the added amount, and changes in hue and physical properties O were measured and evaluated after irradiation with r-rays. The results are also listed in Table 1 above.

安定剤 ム;ジー(2,2,に4−テトラメチル−4−ピペリジ
ル)セバケイト B;コハタ鹸と肩−(2−ヒドロキシエチ&)−4−ヒ
ドロキシ−2,2,46テトラメチルビペリジンとの縮
合物 0at45−トリス(5−にドロキシ−2,4−ジメチ
ル−4−7i@三ブチル−ベンジル)インシアヌレート D;テトツキス〔メチレン(45−ジー第三ブチル−4
−ヒドロキシヒドロシンナメート)〕メタン 2;オクタデシル翫5−ジー第三ブチル−4−ヒドQ中
7ヒドロシンナメート シ:LtA−)リス(2−メチル−S−@三ブチルー4
−ヒドロキシフェノール)ブタン Gニトリ′ス(&5−ジー絽三ブチルー4−にドロキシ
ベンジル)インシアヌレート i[:44’−ブチリデン−ビス(5−メチルー−6−
第三ブチル−フェノール) 工  :t&5−)   リ  メ チ ル −2,4
4−ト  リ ス (&5−ジー第三ブチルー4にドロ
キシベンジル)ベンゼン 実施例2 MシRIL4f710分のポリグロピレンホモボリマー
粉末100重量部に表−2に示す割合の安定剤及びステ
アリン酸カルシウム105重量部を配合し、実施例1と
同様O方法で試験片を成形して五6メガラド0rllJ
t同様に照射17て色相及び物性O変化を評価した結果
を表−2に示した。
Stabilizer M; Di(2,2,4-tetramethyl-4-piperidyl)sebacate B; Kohatasen and 4-(2-hydroxyethyl)-4-hydroxy-2,2,46-tetramethylbiperidine condensation product with 0at45-tris(5-droxy-2,4-dimethyl-4-7i@tributyl-benzyl)in cyanurate D;
-hydroxyhydrocinnamate)] methane 2; octadecyl 5-di-tert-butyl-4-hydro-7 hydrocinnamate in Q: LtA-) lis(2-methyl-S-@tert-butyl-4
-Hydroxyphenol) butane G nitris(&5-di-tributyl-4-droxybenzyl)incyanurate i[:44'-butylidene-bis(5-methyl-6-
Tertiary butyl-phenol) t&5-) methyl -2,4
4-Tris (&5-di-tert-butyl-4 to droxybenzyl)benzene Example 2 100 parts by weight of polyglopylene homopolymer powder of 710 min. stabilizer and calcium stearate in the proportions shown in Table 2 105 parts by weight was blended, and a test piece was molded using the same method as in Example 1 to give 56 megarads.
Table 2 shows the results of evaluating changes in hue and physical properties after irradiation 17 in the same manner as in t.

なお、比較のために本発明O安定剤の組合せを用いない
もOKついて屯同様の評価を行い、その結果を表−2に
併記した。
For comparison, the same evaluation as in Tun was conducted without using the O stabilizer combination of the present invention, and the results are also listed in Table 2.

昭和56年12月24日 特許庁長官 島田春樹殿 1、事件の表示 昭和56年特許願第139805号 2・発明の名称 耐放射線性の改良されたポリプロピレ
ン組成物 3、補正をする者 事件との関係  特許出願人 代表者  松 山   彬 4、代理人 住 所 東京都港区虎ノ門−丁目24番11号6、補正
により増加する発明の数  なしZ補正の対象 (1)  明細書の「発明の詳細な説明」の欄(2)委
任状 a補正の内容 (1)  明細書第5頁末行から第6頁第1行目の「4
−ヒドロキシ−2. 2, 6. 6ーテ(ラメチルピ
リジン」を「4−ヒドロキシ−2. 2, 6. 6−
チトラメチルピベリジン」と訂+Efる。
December 24, 1981 Haruki Shimada, Commissioner of the Patent Office1, Indication of the case, Patent Application No. 139805, filed in 1982, Title of the invention: Polypropylene composition with improved radiation resistance, 3. Related: Patent applicant representative: Akira Matsuyama 4, Agent address: Toranomon-chome-24-11-6, Minato-ku, Tokyo Number of inventions to be increased by amendment None Z Subject of amendment (1) “Details of the invention” in the specification column (2) Contents of amendment to power of attorney a (1) From the last line of page 5 to the first line of page 6 of the specification,
-Hydroxy-2. 2, 6. 6-te(ramethylpyridine) to 4-hydroxy-2.2, 6.6-
Edited as ``Titramethylpiveridine''.

(2)同第9頁第3行目の「6.5メガラドの」次に「
照射量となるように」を挿入する。
(2) On page 9, line 3, “6.5 megarads” is followed by “
Insert "so that the amount of radiation is the same."

(3)  委任状を補充する。(3) Supplement the power of attorney.

j添付書類の目録 (1)委任状  1通 (2)j List of attached documents (1) Power of attorney 1 copy (2)

Claims (1)

【特許請求の範囲】[Claims] ポリプロピレン100重量11K対してヘテロサイクリ
ックヒンダードアミン系化合物(LO5〜1s重量部及
びL&5−)リス(3−ヒドロキシ−L4−ジメチル−
4−フルキル−ベンジル)インシアヌレート(但し、ア
ルキルはOs〜ass C)分岐アルキル基である)(
101〜104重量部とを配合したことを特徴とする耐
放射線性O改喪されえポリプロピレン組成物。
Heterocyclic hindered amine compound (LO5~1s parts by weight and L&5-) lith(3-hydroxy-L4-dimethyl-) per 100 weight 11K of polypropylene
4-Furkyl-benzyl)ine cyanurate (however, alkyl is a branched alkyl group from Os to ass C) (
101 to 104 parts by weight of a radiation-resistant O-modifiable polypropylene composition.
JP13980581A 1981-09-07 1981-09-07 Polypropylene composition having improved radiation resistance Granted JPS5842638A (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
JP13980581A JPS5842638A (en) 1981-09-07 1981-09-07 Polypropylene composition having improved radiation resistance
FR8215128A FR2512453B1 (en) 1981-09-07 1982-09-06 POLYOLEFINIC COMPOSITION HAVING IMPROVED RESISTANCE TO RADIATION AND ITS USE FOR MEDICAL INSTRUMENTS
BE0/208963A BE894327A (en) 1981-09-07 1982-09-07 POLYOLEFIN COMPOSITION HAVING IMPROVED RADIATION RESISTANCE AND USE THEREOF FOR MEDICAL INSTRUMENTS
AU88083/82A AU548837B2 (en) 1981-09-07 1982-09-07 Stabilised polyolefin composition
AU43716/85A AU567617B2 (en) 1981-09-07 1985-06-14 Polyolefin composition with improved radiation resistance and medical instrument made thereof
AU43717/85A AU567618B2 (en) 1981-09-07 1985-06-14 Polyolefin composition with improved radiation resistance and medical instrument made thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP13980581A JPS5842638A (en) 1981-09-07 1981-09-07 Polypropylene composition having improved radiation resistance

Publications (2)

Publication Number Publication Date
JPS5842638A true JPS5842638A (en) 1983-03-12
JPS6235413B2 JPS6235413B2 (en) 1987-08-01

Family

ID=15253841

Family Applications (1)

Application Number Title Priority Date Filing Date
JP13980581A Granted JPS5842638A (en) 1981-09-07 1981-09-07 Polypropylene composition having improved radiation resistance

Country Status (2)

Country Link
JP (1) JPS5842638A (en)
BE (1) BE894327A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5874736A (en) * 1981-10-12 1983-05-06 インペリアル・ケミカル・インダストリ−ズ・パブリツク・リミテイド・カンパニ− Polyolefin composition and products sterilizable by gamma radiation ray
JPS60104146A (en) * 1983-11-11 1985-06-08 Sumitomo Chem Co Ltd Radiation-resistant resin composition
JPS61130358A (en) * 1984-11-30 1986-06-18 Tounen Sekiyu Kagaku Kk Radiation-resistant polyolefin composition
JPH06207108A (en) * 1993-11-26 1994-07-26 Denki Kagaku Kogyo Kk Light-resistant thermoplastic resin composition

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5519199A (en) * 1978-07-25 1980-02-09 Ici Ltd Polyolefin product that can be sterilized by gamma ray irradiation
JPS5662834A (en) * 1979-10-26 1981-05-29 Sumitomo Chem Co Ltd Stabilization of polyolefin against photodeterioration

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5519199A (en) * 1978-07-25 1980-02-09 Ici Ltd Polyolefin product that can be sterilized by gamma ray irradiation
JPS5662834A (en) * 1979-10-26 1981-05-29 Sumitomo Chem Co Ltd Stabilization of polyolefin against photodeterioration

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5874736A (en) * 1981-10-12 1983-05-06 インペリアル・ケミカル・インダストリ−ズ・パブリツク・リミテイド・カンパニ− Polyolefin composition and products sterilizable by gamma radiation ray
JPS60104146A (en) * 1983-11-11 1985-06-08 Sumitomo Chem Co Ltd Radiation-resistant resin composition
JPS61130358A (en) * 1984-11-30 1986-06-18 Tounen Sekiyu Kagaku Kk Radiation-resistant polyolefin composition
JPH054977B2 (en) * 1984-11-30 1993-01-21 Tonen Kagaku Kk
JPH06207108A (en) * 1993-11-26 1994-07-26 Denki Kagaku Kogyo Kk Light-resistant thermoplastic resin composition

Also Published As

Publication number Publication date
JPS6235413B2 (en) 1987-08-01
BE894327A (en) 1983-01-03

Similar Documents

Publication Publication Date Title
US4569736A (en) Medical instruments made from a polyolefin composition which has been sterilized with gamma irradiation
US4666959A (en) Radiation sterilizable propylene polymer compositions and articles manufactured therefrom
US4888369A (en) Polypropylene composition resistant to high energy radiation, and radiation sterilized articles therefrom
EP2568004B1 (en) Anti yellowing composition
KR870002104B1 (en) Radiation stable polypropylene resin composition
JPH0551023B2 (en)
JPS5842638A (en) Polypropylene composition having improved radiation resistance
FR2512453A1 (en) Radiation resistant polyolefin, pref. polypropylene, compsn. - contg. sterically hindered heterocyclic amine, and isocyanurate or phenol phosphite and/or phosphonite cpd.
EP0551062A2 (en) Polymer composition which withstands sterilization carried out by irradiation, and a method for the production thereof
JPH04227742A (en) Radiation-resistant propylene polymer composition and radiation-sterilizable article made therefrom
JPH10114842A (en) Brittling-resistant polyolefin composition and flexible article produced therefrom
GB2043079A (en) High energy radiation treatment of stabilised propylene polymers
EP0303894A2 (en) Radiation sterilizable composition and articles made therefrom
JPH02153953A (en) Radiation-resistant polyolefin composition
JPH04311747A (en) Polypropylene-based resin composition
JPH0449576B2 (en)
JPS60190443A (en) Polypropylene resin composition stable to radiation
JPS58103541A (en) Padiation-resistant polyolefin composition
JPH0410504B2 (en)
JPH0433811B2 (en)
JPH02215848A (en) Radiation-resistant polypropylene resin composition
JPH054977B2 (en)
JPS62235344A (en) Polypropylene resin composition stable to radiation
JPS60212442A (en) Polypropylene resin composition stable to radiation
JPH05209095A (en) Radiation-resistant polypropylene resin composition